Tim Friede
American mechanic and snake collector
Nº Q134481909 ★★
Peu commune · Personnalités
Tim Friede
American mechanic and snake collector
Timothy Friede (born c. 1968) is an American mechanic and snake collector who intentionally exposed himself to various forms of snake venom in order to acquire immunity. A lifelong enthusiast of snakes, he began injecting himself with snake venom in 2000 after taking a venom extraction class.
Dernier prix
—
Prix plancher
—
Médiane 7 j
—
Ventes 30 j
0
Fourchette 30 j
—
En circulation
0
Cours
médiane
min – max
ventes
Aucune vente sur la période
Voir le tableau
| Date | médiane | Min | Max | ventes |
|---|
Historique des ventes
- Dernière vente
- —
- Moyenne 30 j
- —
- Plus bas 30 j
- —
- Plus haut 30 j
- —
- Ventes 7 j
- 0
- Ventes 30 j
- 0
Aucune vente pour l'instant.
Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.
Sur Wikipédia
Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.
Timothy Friede (born c. 1968) is an American mechanic and snake collector who intentionally exposed himself to various forms of snake venom in order to acquire immunity. A lifelong enthusiast of snakes, he began injecting himself with snake venom in 2000 after taking a venom extraction class. After being bitten by two cobras on the same night in 2001 and being left comatose for four days, he resolved to develop an advanced immunity to a variety of snakebites, amassing a collection of over sixty snakes and teaching himself immunology. He injected himself with snake venom over 800 times, and was bitten around 200. After receiving perennial media attention over the 2000s and 2010s, he was contacted by immunologist and biotechnology researcher Jacob Glanville, who saw his acquired resistance as crucial to the development of a broad-spectrum snake antivenom. In a 2025 study published in Cell, two of these antibodies, combined with the anti-inflammatory agent varespladib, proved effective in countering thirteen out of nineteen venoms in a sample of nineteen snake venoms, and was partially effective against the remaining six. He works as the director of herpetology at Glanville's biotechnology company, Centivax.
Texte : Wikipédia en anglais, CC BY-SA 4.0. ·